These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2937370

  • 21. Analytical quantification of the inflammatory cell infiltrate and CD95R expression during treatment of drug-induced toxic epidermal necrolysis.
    Paquet P, Jacob E, Damas P, Pirson J, Piérard G.
    Arch Dermatol Res; 2005 Dec; 297(6):266-73. PubMed ID: 16249890
    [Abstract] [Full Text] [Related]

  • 22. T-cell subsets in cutaneous sarcoidosis.
    Buechner SA, Winkelmann RK, Banks PM.
    Arch Dermatol; 1983 Sep; 119(9):728-32. PubMed ID: 6225400
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemistry of lymphocytes and Langerhans' cells in long-lasting allergic patch tests.
    Kanerva L, Estlander T, Jolanki R.
    Acta Derm Venereol; 1988 Sep; 68(2):116-22. PubMed ID: 2453989
    [Abstract] [Full Text] [Related]

  • 24. In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema.
    Zachary CB, Allen MH, MacDonald DM.
    Br J Dermatol; 1985 Feb; 112(2):149-56. PubMed ID: 3155958
    [Abstract] [Full Text] [Related]

  • 25. T cell subsets in allograft rejection. In situ characterization of T cell subsets in human skin allografts by the use of monoclonal antibodies.
    Bhan AK, Mihm MC, Dvorak HF.
    J Immunol; 1982 Oct; 129(4):1578-83. PubMed ID: 6213716
    [Abstract] [Full Text] [Related]

  • 26. Normal values of peripheral lymphocyte populations and T cell subsets at a fixed time of day: a flow cytometric analysis with monoclonal antibodies in 210 healthy adults.
    Ohta Y, Fujiwara K, Nishi T, Oka H.
    Clin Exp Immunol; 1986 Apr; 64(1):146-9. PubMed ID: 2942319
    [Abstract] [Full Text] [Related]

  • 27. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
    Rabin BS, Johnson J, Claassen D.
    Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
    [Abstract] [Full Text] [Related]

  • 28. Animal models of toxic epidermal necrolysis.
    Azukizawa H.
    J Dermatol; 2011 Mar; 38(3):255-60. PubMed ID: 21342227
    [Abstract] [Full Text] [Related]

  • 29. In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis.
    Colucci G, Colombo M, Del Ninno E, Paronetto F.
    Gastroenterology; 1983 Nov; 85(5):1138-45. PubMed ID: 6225691
    [Abstract] [Full Text] [Related]

  • 30. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells.
    Moulon C, Péguet-Navarro J, Courtellemont P, Redziniak G, Schmitt D.
    Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088
    [Abstract] [Full Text] [Related]

  • 31. Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association.
    Paquet P, Jacob E, Pirson J, Pierard GE.
    Int J Mol Med; 2005 Jul; 16(1):29-33. PubMed ID: 15942674
    [Abstract] [Full Text] [Related]

  • 32. Further phenotypic characterization of T cells after human allogeneic bone marrow transplantation.
    Elfenbein GJ, Ashkenazi YJ, Barth KC.
    Transplantation; 1985 Jan; 39(1):97-102. PubMed ID: 3155580
    [No Abstract] [Full Text] [Related]

  • 33. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D, Thivolet J.
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [Abstract] [Full Text] [Related]

  • 34. Lymphocyte subsets and specific T-cell immune response in thalassemia.
    Pattanapanyasat K, Thepthai C, Lamchiagdhase P, Lerdwana S, Tachavanich K, Thanomsuk P, Wanachiwanawin W, Fucharoen S, Darden JM.
    Cytometry; 2000 Feb 15; 42(1):11-7. PubMed ID: 10679738
    [Abstract] [Full Text] [Related]

  • 35. Characterization of T lymphocyte subsets with monoclonal antibodies: discovery of a distinct marker, Ly-m22, of T suppressor cells.
    Chan MM, Tada N, Kimura S, Hoffmann MK, Miller RA, Stutman O, Hämmerling U.
    J Immunol; 1983 May 15; 130(5):2075-8. PubMed ID: 6187835
    [Abstract] [Full Text] [Related]

  • 36. Further dissection of the functional heterogeneity within the OKT4+ and OKT8+ human T cell subsets.
    Thomas Y, Rogozinski L, Rothman P, Rabbani LE, Andrews S, Irigoyen OH, Chess L.
    J Clin Immunol; 1982 Jul 15; 2(3 Suppl):8S-14S. PubMed ID: 6215426
    [Abstract] [Full Text] [Related]

  • 37. Functional heterogeneity of CD4+ T lymphocytes: two subpopulations with counteracting immunoregulatory functions identified with the monoclonal antibodies WR16 and WR19.
    Moore K, Nesbitt AM.
    Immunology; 1987 Jun 15; 61(2):159-65. PubMed ID: 2954898
    [Abstract] [Full Text] [Related]

  • 38. Activated T cells in Graves' disease before treatment.
    Kennedy R, Di Mario U, Pozzilli P, Guy K, Leonardi M, Sensi M, Andreani D.
    Clin Exp Immunol; 1985 Feb 15; 59(2):377-82. PubMed ID: 3156702
    [Abstract] [Full Text] [Related]

  • 39. Immunological mechanisms of epidermal damage in toxic epidermal necrolysis.
    Tohyama M, Hashimoto K.
    Curr Opin Allergy Clin Immunol; 2012 Aug 15; 12(4):376-82. PubMed ID: 22688730
    [Abstract] [Full Text] [Related]

  • 40. Inflammatory cell types in normal human epidermis--an immunohistochemical and morphometric study.
    Smolle J, Ehall R, Kerl H.
    Acta Derm Venereol; 1985 Aug 15; 65(6):479-83. PubMed ID: 2420110
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.